...Good morning. I'm Jeremy Levin, Chairman of the Board of Directors and Chief Executive Officer of Ovid Therapeutics. And it's my pleasure to welcome you to the company's 2025 Annual Meeting of Stockholders. It is now after 10:30 AM and I will call this meeting to order and proceed with introductions and formal business of the annual meeting. I would like to start off by thanking everyone for joining us today. Please let me introduce the members of our senior management present today. Jeff Rona, Chief Business and Financial Officer and Corporate Secretary; Meg Alexander, President and Chief Operating Officer. We're also pleased to introduce the other members of our Board of Directors who joined us today, Bart Friedman and Barbara Duncan. I'd like to introduce Joseph Epstein of KPMG LLP, our independent registered public accounting firm, who is available to respond to appropriate questions as needed. And finally, the company has appointed Mr. Peter Descovich of IOE Services Inc., to act as...